PAUL A FRIEDMAN Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL A FRIEDMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL A FRIEDMAN. PAUL A FRIEDMAN is Chief Executive Officer in INCYTE CORP ($INCY) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Cerulean Pharma Inc. ($CERU) and Director in Verastem, Inc. ($VSTM) and Director in Prelude Therapeutics Inc ($PRLD).

Latest Insider Trading Transactions of PAUL A FRIEDMAN

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALXN, DARE, INCY, SNTA, PRLD, VSTM

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 22 2021PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseA31.0223,344724,13123,344
Feb 23 2021SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA119.4950,0005,974,50050,000
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseC0.00152,57600
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseC0.00295,79400
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseP0.0076,2880152,576
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorBuyC0.00152,5760500,098347.5 K to 500.1 K (+43.90 %)
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorBuyC0.00295,7940347,52251.7 K to 347.5 K (+571.83 %)
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseC0.00152,57600
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseC0.00295,79400
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorOption ExerciseP0.0076,2880152,576
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorBuyC0.00152,5760500,098347.5 K to 500.1 K (+43.90 %)
Sep 30 2020PRLDPrelude Therapeuti ...FRIEDMAN PAUL ADirectorBuyC0.00295,7940347,52251.7 K to 347.5 K (+571.83 %)
May 28 2020INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseA98.6810,5141,037,52210,514
May 28 2020INCYINCYTE CORPFRIEDMAN PAUL ADirectorGrantA0.001,2820256,813255.5 K to 256.8 K (+0.50 %)
May 18 2020ALXNALEXION PHARMACEUT ...FRIEDMAN PAUL ADirectorGrantA0.003,468010,3456.9 K to 10.3 K (+50.43 %)
Mar 05 2020SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA91.7950,0004,589,50050,000
Aug 06 2019INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM18.3277,9341,427,7510
Aug 06 2019INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM18.3222,066404,24977,934
Aug 06 2019INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS82.2077,9346,406,175255,531333.5 K to 255.5 K (-23.37 %)
Aug 06 2019INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM18.3277,9341,427,751333,465255.5 K to 333.5 K (+30.50 %)
Aug 06 2019INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS84.4122,0661,862,591255,531277.6 K to 255.5 K (-7.95 %)
Aug 06 2019INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM18.3222,066404,249277,597255.5 K to 277.6 K (+8.64 %)
Apr 29 2019INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseA75.0312,472935,77412,472
Apr 29 2019INCYINCYTE CORPFRIEDMAN PAUL ADirectorGrantA0.001,5200255,531254 K to 255.5 K (+0.60 %)
Mar 11 2019SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA127.9650,0006,398,00050,000
Nov 23 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...BuyP117.884,000471,520161,128157.1 K to 161.1 K (+2.55 %)
Nov 19 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...BuyP124.004,000496,000157,128153.1 K to 157.1 K (+2.61 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...SellS287.4673,52621,135,784655,540729.1 K to 655.5 K (-10.08 %)
Jun 12 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...SellS287.4673,52621,135,784655,540729.1 K to 655.5 K (-10.08 %)
May 11 2018ALXNALEXION PHARMACEUT ...FRIEDMAN PAUL ADirectorGrantA0.002,17404,1512 K to 4.2 K (+109.96 %)
May 03 2018INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseA60.8515,000912,75015,000
Mar 05 2018SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA124.4550,0006,222,50050,000
Nov 30 2017ALXNALEXION PHARMACEUT ...FRIEDMAN PAUL ADirectorGrantA0.001,97701,9770 to 2 K
Nov 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS105.2428,5073,000,077269,011297.5 K to 269 K (-9.58 %)
May 31 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseA134.3815,0002,015,70015,000
Apr 05 2017CERUCerulean Pharma In ...FRIEDMAN PAUL ADirectorGrantA0.7310,2737,49918,8198.5 K to 18.8 K (+120.21 %)
Mar 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM18.3241,693763,816100,000
Mar 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM18.322,84952,194141,693
Mar 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM18.325,45899,9910
Mar 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS148.1841,6936,178,069297,518339.2 K to 297.5 K (-12.29 %)
Mar 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM18.3241,693763,816339,211297.5 K to 339.2 K (+14.01 %)
Mar 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS151.458,3071,258,095297,518305.8 K to 297.5 K (-2.72 %)
Mar 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM18.322,84952,194305,825303 K to 305.8 K (+0.94 %)
Mar 20 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM18.325,45899,991302,976297.5 K to 303 K (+1.83 %)
Mar 06 2017SNTAMADRIGAL PHARMACEU ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA15.8049,600783,68049,600
Feb 27 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM18.3250,000916,000144,542
Feb 27 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS120.3250,0006,016,000297,518347.5 K to 297.5 K (-14.39 %)
Feb 27 2017INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM18.3250,000916,000347,518297.5 K to 347.5 K (+16.81 %)
Jan 05 2017CERUCerulean Pharma In ...FRIEDMAN PAUL ADirectorGrantA0.774,8703,7508,5463.7 K to 8.5 K (+132.48 %)
Oct 20 2016CERUCerulean Pharma In ...FRIEDMAN PAUL ADirectorGrantA1.023,6763,7503,6760 to 3.7 K
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...Option ExerciseA9.45287,1152,713,237287,115
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.00729,0660729,0660 to 729.1 K
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.00143,5570143,703146 to 143.7 K (+98,326.71 %)
Jul 26 2016SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL AChief Executive Off ...GrantA0.0014601460 to 146
Jun 24 2016CERUCerulean Pharma In ...FRIEDMAN PAUL ADirectorOption ExerciseA2.0820,00041,60020,000
Jun 16 2016VSTMVerastem, Inc.FRIEDMAN PAUL ADirectorOption ExerciseA1.3725,00034,25025,000
May 31 2016INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseA84.5315,0001,267,95015,000
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM17.79125,0002,223,7500
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM17.7994,3791,679,002125,000
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM17.795,62199,9980
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS115.1238,8684,474,484297,518336.4 K to 297.5 K (-11.55 %)
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS115.4286,1329,941,355336,386422.5 K to 336.4 K (-20.39 %)
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM17.79125,0002,223,750422,518297.5 K to 422.5 K (+42.01 %)
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS111.3750,0005,568,500297,518347.5 K to 297.5 K (-14.39 %)
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS112.5342,9484,832,938347,518390.5 K to 347.5 K (-11.00 %)
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS112.717,052794,831390,466397.5 K to 390.5 K (-1.77 %)
Nov 19 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM17.79100,0001,779,000397,518297.5 K to 397.5 K (+33.61 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorOption ExerciseA2.2020,00044,00020,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorGrantA0.001,13606,8175.7 K to 6.8 K (+20.00 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorGrantA0.005,68105,6810 to 5.7 K
Jun 30 2015CERUCerulean Pharma In ...FRIEDMAN PAUL ADirectorOption ExerciseA4.7811,00052,58011,000
Jun 30 2015CERUCerulean Pharma In ...FRIEDMAN PAUL ADirectorOption ExerciseA4.788,21439,2638,214
Jun 16 2015VSTMVerastem, Inc.FRIEDMAN PAUL ADirectorOption ExerciseA7.9919,495155,76519,495
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM14.7269,1321,017,6230
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM14.72127,6191,878,55269,132
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.1916,4361,761,775297,518314 K to 297.5 K (-5.24 %)
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.6652,6965,673,251313,954366.7 K to 314 K (-14.37 %)
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM14.7269,1321,017,623366,650297.5 K to 366.7 K (+23.24 %)
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.1522,6422,426,090297,518320.2 K to 297.5 K (-7.07 %)
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.0050,0005,350,000320,160370.2 K to 320.2 K (-13.51 %)
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.362,358253,155370,160372.5 K to 370.2 K (-0.63 %)
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.0050,0005,350,000372,518422.5 K to 372.5 K (-11.83 %)
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.832,619282,407422,518425.1 K to 422.5 K (-0.62 %)
May 28 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM14.72127,6191,878,552425,137297.5 K to 425.1 K (+42.89 %)
May 27 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseA107.6915,0001,615,35015,000
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM14.7279,5921,171,594196,751
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM14.7213,846203,813276,343
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorOption ExerciseM14.728,805129,6100
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.8825,0002,697,000297,518322.5 K to 297.5 K (-7.75 %)
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS107.7525,0002,693,750322,518347.5 K to 322.5 K (-7.19 %)
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS108.5015,2001,649,200347,518362.7 K to 347.5 K (-4.19 %)
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS108.3414,3921,559,229362,718377.1 K to 362.7 K (-3.82 %)
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM14.7279,5921,171,594377,110297.5 K to 377.1 K (+26.75 %)
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS108.9214,3881,567,141297,518311.9 K to 297.5 K (-4.61 %)
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorSellS108.758,263898,601311,906320.2 K to 311.9 K (-2.58 %)
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM14.7213,846203,813320,169306.3 K to 320.2 K (+4.52 %)
May 26 2015INCYINCYTE CORPFRIEDMAN PAUL ADirectorBuyM14.728,805129,610306,323297.5 K to 306.3 K (+2.96 %)
Mar 02 2004INCYINCYTE CORPFRIEDMAN PAUL AChief Executive Off ...Option ExerciseA8.6443,125372,600187,684
Mar 02 2004INCYINCYTE CORPFRIEDMAN PAUL AChief Executive Off ...Option ExerciseA8.64144,5591,248,990144,559
Mar 02 2004INCYINCYTE CORPFRIEDMAN PAUL AChief Executive Off ...Option ExerciseA8.641,87516,20032,316
Mar 02 2004INCYINCYTE CORPFRIEDMAN PAUL AChief Executive Off ...Option ExerciseA8.6430,441263,01030,441

Page:   1